Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 166

DEA Research and Development Clinical Trials Marijuana 166

Cannabis Law Report

JUNE 24, 2022

The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws. Marijuana Moment reports.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 10, 2022

Controlled research into psilocybin for therapeutic purposes reveals that it may allow people suffering from depression, anxiety, PTSD, and potentially addiction, to more easily face and overcome painful or stressful memories and experiences. Background. Psilocybin. Psilocybin is the hallucinogenic chemical found in “magic mushrooms.”

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

SEPTEMBER 23, 2022

Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of psychedelics. Policy and Advocacy Director, MAPS . As a result, the soon-to-be-amended version of SB 519 is limited to a study.”.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Click here to email your lawmakers in support of legalization. PA resident? Additional Actions to Take.

Legislation 127

Legislation Clinical Trials Research and Development Access 127

Cannabis Law Report

NOVEMBER 23, 2021

. “If a small number of companies secure wide swaths of intellectual property early on, then the beneficial impact of that shift may be blunted,” warn researchers. Glenn Cohen analyzed the ethical, legal, and social implications of patenting psychedelics. Read more at [link]. Harvard Law Review Forum, Vol. Mason Marks.

Law 52

Law Research and Development Therapy Clinical Trials 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

MMJ Recs

DECEMBER 22, 2023

As the United States navigates through a complex web of legal, social, and medical considerations, public opinion on medical cannabis has evolved significantly over the years. The changing public opinion is evident in the increasing number of states legalizing medical cannabis and the growing support for such measures.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. The right candidate will have a passion for clinical research in novel therapeutics to address unmet medical need and a proven track record of success in regulatory affairs.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

MMJ Recs

DECEMBER 17, 2023

Low-THC Cannabis: According to the legal status of THC in Texas medical marijuana, the program only permits the use of MMJ with low tetrahydrocannabinol (THC) content. Any potential expansion of patient rights would likely depend on future legislative changes and developments in the state’s approach to medical marijuana.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

JUNE 9, 2022

Ukraine’s Health Minister Viktor Liashko announced on June 7 that the government had backed the bill that would legalize medical cannabis amid the war with Russia. The bill aims to improve the quality of medical services for the population that undergoes palliative medicine and encourage medical research on cannabis.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The research we completed is exploratory but the results are consistent with our earlier research. “The We look forward to the next chapters in their development”. federal law.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

JULY 13, 2019

clinical trials have been made by Members of Parliament. After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. CBD Testers.co Source: [link].

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40

CannaTech

JANUARY 27, 2019

The Latin American investment opportunities range from scientific research for pharmaceuticals to formulated products for nutraceuticals, and everything that is required in between (e.g. From clinical trials to cosmetics, the region is gearing up for high return and low cost of production. land, labs, licenses).

Clinical Trials 81

Clinical Trials Cultivation Research and Development Cannabis 81

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

APRIL 10, 2019

These include “to initiate a process evaluation to address barriers” and to ask “the National Institute for Health Research and the industry to take action to produce … evidence in a form that will support decisions about public funding.”. We are working hard to get the right approach.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

JULY 25, 2022

Conversation Tackles MAPS Research Methadology & Issues Of Abuse In Therapy. Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. ” Underground researcher. . she says.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). Regardless all these regulatory developments, what did change, in fact?

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

DECEMBER 20, 2021

The three states that presently have a policy on hemp cultivation are Uttarakhand, Uttar Pradesh, and Madhya Pradesh. The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules. Recent Development. Cannabis is a Schedule E(1) drug under the Drugs & Cosmetics Rules, 1945 9.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. In the UK, cannabis-based medicinal products (CBMP) were legalized in November 2018.

Patients 79

Patients Policy Clinical Trials Research and Development 79

The Cannigma

MARCH 12, 2021

Listen & Subscribe: Very few medical cannabis advocates are against the full legalization of the plant for all adults. But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. What is the relationship between medical and recreational legalization?

Legalization 128

Legalization Patients Education Dispensary 128

Canna Law Blog

NOVEMBER 6, 2021

Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Research was permitted in the mid-20th century, until the law stepped in.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). This post is dedicated to clearing up some of the confusion behind ketamine clinic set-up and operation.

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Cannabis Law Report

AUGUST 25, 2022

The MAPS Policy and Advocacy team coordinated a bipartisan coalition that met with U.S. The criminal legal system has unjustly stigmatized and punished individuals for the choices they make about what to put in their own bodies. Policy and Advocacy Director, MAPS. Senators and monitored the progress of the confirmation process.

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52

CannaMD

MARCH 8, 2021

Luckily, you know you can always count on CannaMD to provide the research you need to fight fire with fire! 1455 – and how YOU can fight back with research-based arguments! However, peer-reviewed research paints a more complex picture. Industry advocate, medical professional, or politician looking for more details? Florida H.B.

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

NOVEMBER 12, 2021

As security for the Facility, five members of KCP (the “Guarantors”) provided personal deeds of guarantee (each limited to £200,000) alongside a legal charge granted in favour of Brown Shipley dated 31 August 2021 (the “Charge”) over the 198,466,493 ordinary shares of £0.01 Caution regarding forward looking statements.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 71

DEA Research and Development Cultivation Supply Chain 71

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Now, we are closer than ever to legalizing MDMA-assisted therapy for posttraumatic stress disorder (PTSD), though there is still a long road ahead. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 1, 2022

The Psychedelic Bar Association (PBA) is an association of attorneys and legal professionals dedicated to solving the novel legal and policy issues impacting the emerging psychedelics sector. The PBA Religious Use Committee provides expertise around the intersections of law, policy, psychedelics, and religion.

Safety 52

Safety History Programs Clinical Trials 52

Cannabis Law Report

OCTOBER 3, 2019

Cannabis was high on the regulatory agenda in September, with two significant developments: 1. It is hoped that, as a result of these changes, medicinal cannabis products will be more readily and easily accessible to patients through legal channels. Authored By: Executive summary. Key findings. The Final Report found that: 1.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

The Cannigma

MAY 7, 2021

MSO: There’s a lot I want to talk about but the thing that’s on my mind specifically is the way that – or the pace that North America and the Americas in general have been moving on cannabis liberalization and legalization as compared to Europe.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

AUGUST 30, 2019

Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. Governor Ducey (R-AZ) opposes legalization.

Banking 45

Banking Research and Development Legislation Programs 45

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Cannabis Law Report

JUNE 4, 2021

Scientific accomplishments (developments, discoveries, etc.). Psychedelic Invest’s intention with this publication is to raise awareness to a broader audience, in order to further develop the psychedelics ecosystem in a positive and sustainable manner. Hamilton Morris is an American journalist, documentarian, and scientific researcher.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51